European genetic ancestry associated with risk of childhood ependymoma.
European genetic ancestry associated with risk of childhood ependymoma.
复制标题
欧洲遗传血统与儿童室管膜瘤的风险相关。
DOI:
10.1093/neuonc/noaa130
复制
发表时间:
2020
期刊:
影响因子:
15.9
通讯作者:
Barnholtz-Sloan,Jill
中科院分区:
文献类型:
--
作者:
Zhang,Chenan;Ostrom,QuinnT;Hansen,HelenM;Gonzalez-Maya,Julio;Hu,Donglei;Ziv,Elad;Morimoto,Libby;deSmith,AdamJ;Muskens,IvoS;Kline,CassieN;Vaksman,Zalman;Hakonarson,Hakon;Diskin,SharonJ;Kruchko,Carol;Barnholtz-Sloan,Jill
BackgroundEpendymoma is a histologically defined central nervous system tumor most commonly occurring in childhood. Population-level incidence differences by race/ethnicity are observed, with individuals of European ancestry at highest risk. We aimed to determine whether extent of European genetic ancestry is associated with ependymoma risk in US populations.MethodsIn a multi-ethnic study of Californian children (327 cases, 1970 controls), we estimated the proportions of European, African, and Native American ancestry among recently admixed Hispanic and African American subjects and estimated European admixture among non-Hispanic white subjects using genome-wide data. We tested whether genome-wide ancestry differences were associated with ependymoma risk and performed admixture mapping to identify associations with local ancestry. We also evaluated race/ethnicity-stratified ependymoma incidence data from the Central Brain Tumor Registry of the United States (CBTRUS).ResultsCBTRUS data revealed that African American and Native American children have 33% and 36%, respectively, reduced incidence of ependymoma compared with non-Hispanic whites. In genetic analyses, a 20% increase in European ancestry was associated with a 1.31-fold higher odds of ependymoma among self-reported Hispanics and African Americans (95% CI: 1.08–1.59,Pmeta= 6.7 × 10−3). Additionally, eastern European ancestral substructure was associated with increased ependymoma risk in non-Hispanic whites (P= 0.030) and in Hispanics (P= 0.043). Admixture mapping revealed a peak at 20p13 associated with increased local European ancestry, and targeted fine-mapping identified a lead variant at rs6039499 nearRSPO4(odds ratio = 1.99; 95% CI: 1.45–2.73;P= 2.2 × 10−5) but which was not validated in an independent set of posterior fossa type A patients.ConclusionsInterethnic differences in ependymoma risk are recapitulated in the genomic ancestry of ependymoma patients, implicating regions to target in future association studies.